喷布洛尔治疗高血压：一种新型β-肾上腺素能阻滞剂的评估
Penbutolol in hypertension: evaluation of a new beta-adrenergic blocking drug.
作者信息
Bett J H, Wilkinson R K, Williams J, Ryan H
出版信息
Med J Aust. 1980 Jan 12;1(1):30-1.
PMID:6987484
Abstract
The hypotensive effect of penbutolol, a new beta-adrenergic blocking drug, has been evaluated in a doulbe-blind crossover trial on 15 patients. Blood pressures were significantly lower during active drug treatment (P less than 0.001), the average reduction being: 1.7/0.9 kPa (13/7 mmHg) erect.
摘要
新型β-肾上腺素能阻滞剂喷布洛尔的降压作用在15例患者中进行了双盲交叉试验评估。在使用活性药物治疗期间血压显著降低（P<0.001），直立位时平均降低幅度为：1.7/0.9千帕（13/7毫米汞柱）。
Zotero 插件